Matrix Metalloproteinase-3 Gene Polymorphisms (A(-267)G, A658G, T813C) is Associated with Type 2 Diabetes in Koreans
![]() |
Yoo, Min
(Department of Biology, College of Natural Sciences, Keimyung University)
Kim, Hyo-Jeong (Department of Biology, College of Natural Sciences, Keimyung University) Qing, Ye (Department of Biology, College of Natural Sciences, Keimyung University) Kim, Jong-Won (Department of Biology, College of Natural Sciences, Keimyung University) Kim, Su-Won (Department of Biology, College of Natural Sciences, Keimyung University) |
1 | Poollanen, P. J., T. Lehtimaki, E. Ilveskoski, J. Mikkelsson, O. A. Kajander, P. Laippala, M. Perola, S. Goebeler, A. Penttila, K. M. Mattila, K. Syrjakoski, T. Koivula, S. T. Nikkari, and P. J. Karhunen. 2002. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis 164, 329-335. DOI |
2 | Reaven, G. M. 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607. DOI |
3 | Robertson, W. B., J. P. Strong. 1968. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab. lnvest. 18, 538-551. |
4 | Ross, R. 1993. The pathogenesis of atherosclerosis; a perspective for the 1990s. Nature 362, 801-809. DOI ScienceOn |
5 | Schernthaner, G. 1996. Cardiovascular mortaality and morbidity in type-2 diabetes mellitus. Diabetes Res. Clin. Pract. 31, Suppl. S3-13. DOI |
6 | Fukuyama, K., T. Ohara, Y. Hirota, K. Maeda, S. Kuno, M. Zenibayashi, T. Teranishi, K. Kouyama, E. Maeda, N. Sakamoto, and M. Ksauga. 2006. Association of the -112a>c polymorphism of the uncoupling protein 1 gene with insulin resistance in Japanese individuals with type 2 diabetes. Biochem. Biophys. Res. Commun. 339, 1212-1216. DOI |
7 | Gloyn, A. L., Y. Hashim, S. J. Aschcroft, R. Ashfield, S. Wiltshire, and R. C. Turmer. 2001. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). Diabet. Med. 18, 206-212. DOI |
8 | Goldbourt, U. and H. N. Neufeld. 1986. Genetic aspects of arteriosclerosis. Arteriosclerosis 6, 357-377. DOI |
9 | Groop, L., C. Forsblom, M. Lehtovirta, T. Tuomi, S. Karanko, M. Nissen, B. O. Ehrnstrom, B. Forsen, B. Isomaa, B. Snickars, and M. R. Taskinen. 1996. Metabolic consequences of family history of NIDDM (The Botnia Study). Diabetes 45, 1585-1593. DOI |
10 | Chung, A. W. Y., H. Luo, T. Tejerina, C. V. Breemena, and E. B. Okon. 2007. Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and down regulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature. Atherosclerosis 195, 1-8. DOI |
11 | Doney, A. S., B. Fischer, J. E. Cecil, K. Boylan, F. E. McGuigan, S. H. Ralston, A. D. Morris, and C. N. Palmer. 2004. Association of the pro12ala and c1431t variants of PPARg and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47, 555-558. DOI |
12 | Egeblad, M. and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2, 161-174. DOI |
13 | Ferrara, N. 2001. Role of vasclar endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280, 1358-1366. |
14 | Lee, J. E., Y. K. Choi, H. A. Seo, J. H. Jeong, J. Y. Jeong, S. S. Moon, J. G. Kim, B. W. Kim, S. W. Kim, M. Yoo, J. Y. Kim, and I. K. Lee. 2010. Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetesin a Korean population. Diabetes Res. and Clin. Prac. 88, 87-96. DOI |
15 | Grundy, S. M. 1999. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F-29F. |
16 | Hojilla, C. V., F. F. Mohammed, and R. Khokha. 2003. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. British J. Cancer 89, 1817-1821. DOI |
17 | Hu, F. B. and A. Doria. 2004. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53, 209-213. DOI |
18 | Ye, S. 2006. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovascular Research 69, 636-645. DOI |
19 | Stimvoll, M., B. J Goldstein, and T. W. van Gaeften. 2005. Type 2 diabetes; principles of pathogenesis and therapy. Lacet 365, 1333-1346. |
20 | Wang, H., and J. A. Keiser. 1998. Vascular endothelial growth factor upregulatesthe expression of matrix metalloproteinase in vascular smooth muscle cells; role of flt-1. Circ. Res. 83, 832-840. DOI ScienceOn |
21 | Zhang, C., L. Qi, D. J. Humter, J. B. Meigs, J. E. Manson, R. M. van Dam, and F. B. Hu. 2006. Variant of transcription factor 7-like 2 (tcf7l2) gene and the risk of type 2 diabetes in large cohorts of U. S. Women and men. Diabetes 55, 2645-2648. DOI |
22 | Zimmet, P. 2002. Addressing the insulin resistance syndrome. TCM. 12, 354-362. |
23 | Nam, J. H. and K. S. Park. 2004. Single nucleotide polymorphisms of matrix metalloproteinase in Koreans. Kor. J. Genetics 26, 289-296. |
24 | Medley, T. L., B. A. Kingwell, C. D. Gatzka, P. Pillay, and T. J. Cole. 2003. Matrix metallopreteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res. 92, 1254-1261. DOI |
25 | Mensah, G. A., A. H. Mokdad, E. Ford, K. M. Narayan, W. H. Giles, F. Vinicor, and P. C. Deedwania. 2004. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implication. Cardiol. Clin. 22, 485-504. DOI |
26 | Musi, N. 2006. AMP-activated protein kinase and type 2 diabetes. Curr. Med. Chem. 13, 583-589. DOI |
27 | Newby, A. C. 2005. Dual role of matrix metalloproteinases in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31. DOI |
![]() |